| Target Price | $4.59 |
| Price | $2.74 |
| Potential |
67.52%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Definitive Healthcare 2026 .
The average Definitive Healthcare target price is $4.59.
This is
67.52%
register free of charge
$6.30
129.93%
register free of charge
$3.03
10.58%
register free of charge
|
|
| A rating was issued by 21 analysts: 10 Analysts recommend Definitive Healthcare to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Definitive Healthcare stock has an average upside potential 2026 of
67.52%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 252.20 | 245.58 |
| 0.31% | 2.62% | |
| EBITDA Margin | 11.05% | 27.54% |
| 243.13% | 149.12% | |
| Net Margin | -163.81% | 13.66% |
| 103.49% | 108.34% |
16 Analysts have issued a sales forecast Definitive Healthcare 2025 . The average Definitive Healthcare sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Definitive Healthcare EBITDA forecast 2025. The average Definitive Healthcare EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
16 Definitive Healthcare Analysts have issued a net profit forecast 2025. The average Definitive Healthcare net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.54 | 0.23 |
| 97.77% | 106.50% | |
| P/E | 11.69 | |
| EV/Sales | 1.52 |
16 Analysts have issued a Definitive Healthcare forecast for earnings per share. The average Definitive Healthcare EPS is
This results in the following potential growth metrics and future valuations:
Definitive Healthcare...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 10 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | May 12 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jan 16 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 10 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 12 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jan 16 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jan 13 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


